Advanced Filters
noise

Depression Clinical Trials

A listing of Depression medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,234 clinical trials
C Catherine J Harmer, DPhil

Nitrous Oxide and EMOtional Cognition

The goal of this study is to uncover the underlying neuropsychological mechanisms of nitrous oxide, which may be relevant to its reported antidepressant effects. In particular, the study is designed to determine whether nitrous oxide changes the way in which healthy volunteers aged 18-40 years remember negative autobiographical memories. The …

18 - 40 years of age All Phase N/A
Z Zhenghui Yi, M.D

A Study of Mianserin in Combination With SSRIs in Depression With Sleep Problems

Patients with depression with sleep problems have functional abnormalities of 5-HT and NE neurotransmitters, and the NaSSA class antidepressant mianserin has an ameliorative effect on sleep problems along with antidepressant. However, whether mianserin can improve cognitive function in patients still needs to be explored. The benzodiazepine lorazepam can play a …

18 - 60 years of age All Phase 4
K Katie Tucker

fMRI Accelerated TMS Depression

This study aims to investigate whether phenotypic-related brain states revealed by a novel INSCAPE ("Individualized Network-based Single-frame Coactivation Pattern Estimation") neuroimaging method in Major Depressive Disorder (MDD) patients can track brain recovery of MDD patients over an accelerated antidepressant transcranial magnetic stimulation (TMS) treatment.

18 - 65 years of age All Phase N/A
J Jill Cumby, RN

Feedback to Improve Depression Outcomes

Depression is a leading cause of burden in Canada and globally. Although more people now seek and receive treatment for depression, there are still many who do not respond well to treatments. New and low-cost options are needed to improve the lives of people with depression. Research suggests that asking …

18 years of age All Phase N/A
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)

Background Researchers developed \[11C\]MC1, a radioligand for cyclooxygenase-2 (COX-2). COX-2 is an enzyme induced in the brain during inflammation. Researchers want to see the levels of COX-1 (measured as distribution volume VT) are elevated in the brain of two groups of mood disorders patients undergoing MDE relative to the control …

18 - 70 years of age All Phase 1

Behavioral Self-activation and Virtual Reality in Depression

Depression is a major handicap in daily life and is often treated by behavioral activation (CA), including the Brief Behavioral Activation Treatment for Depression (BATD).The CA principle is to set up activities, in keeping with the values of the individual. Other tools associated with the CA deserve to be explored …

18 - 70 years of age All Phase N/A
E Elina Santti, PhD

Dance-movement Therapy in the Treatment of Adolescent Depression

The aim of this research is to measure the effectiveness of Dance movement therapy in the treatment of adolescent depression.

13 - 17 years of age All Phase N/A
S Shelley Cates

Researching Heat and Yoga for Mood Enhancement

This study will examine how doing heated yoga or non-heated yoga affects depression.

18 - 65 years of age All Phase N/A
Y Young Kim-wan, PhD

Sound Bite-- a Therapeutic Song-writing Program

The research aims to investigate the effectiveness of the therapeutic song-writing program on young people with depressive symptoms. This study adopts a multicentre randomized control trial two arms research design. A randomised controlled trial will compare a typical 7-session therapeutic song-writing program with a waitlist-control group to determine whether the …

13 - 24 years of age All Phase N/A
M Mostafa M Bahaa, PhD

Dapagliflozin in Depression

Major depressive disorder (MDD) is currently one of the leading causes of disability and suicidal death worldwide, and despite extensive research and massive improvements in mental health, the nature of MDD remains ambiguous. Moreover, about two-thirds of MDD patients fail to optimally respond to currently available standard therapies, and many …

18 - 60 years of age All Phase 1/2

Simplify language using AI